Study

Alzheimer’s Agitation Study

New drug trial tests medication that could provide relief.

What is agitation in Alzheimer's?

Agitation in all its forms—from finger tapping, nail biting and restlessness to excessive motor activity, verbal aggression, and physical aggression—is particularly challenging because there are currently no effective treatments for it.

This study medication holds promise in possibly relieving agitation, which appears in 40%-60% of Alzheimer patients and in 75% of moderate-to-severe dementia sufferers.

“It may be very difficult to deal with some of these patients,” says Dr. Edgardo Rivera, Charter Research’s medical director in Orlando. “They encounter problems with daily living earlier than patients who are not agitated. These patients tend to be moved to nursing homes earlier.”

PLEASE NOTE: This study is only enrolling at our Orlando location.

Who is eligible?

You may qualify for this study if:

The potential study volunteer is 55+ years of age.
There is a confirmed high likelihood of Alzheimer's disease, using either a blood-based biomarker or cerebrospinal fluid biomarker.
One of more of the following are present: excessive motor activity, verbal aggression, physical aggression.
Agitation is not solely attributable to another psychiatric, medical, or environmental condition.

Sign Up

Schedule Your Assessment

Sign up for an initial assessment (called a “prescreen”), and we'll give you a call. One of our professional medical staff will answer your questions and give you more information about Charter Research prior to an in-office visit.